TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

TNFα-Antagonist Use and Mucosal Inflammation Are Associated with Increased Intestinal Expression of SARS-CoV-2 Host Protease TMPRSS2 in Patients with Inflammatory Bowel Disease

Published:2021-06 Issue:7 Volume:160 Page:2621-2622
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Bangma Amber,Voskuil Michiel D.^ORCID,Weersma Rinse K.

Funder

Maag Lever Darm Stichting

AbbVie

Takeda Pharmaceutical Company

Johnson and Johnson

Janssen Pharmaceuticals

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference4 articles.

1. Age, Inflammation, and Disease Location Are Critical Determinants of Intestinal Expression of SARS-CoV-2 Receptor ACE2 and TMPRSS2 in Inflammatory Bowel Disease

2. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

3. SARS-CoV-2 productively infects human gut enterocytes

4. The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Post-Acute Sequelae of Covid-19: A System-wise Approach on the Effects of Long-Covid-19;American Journal of Medicine Open;2024-12

2. COVID-19 and Gastrointestinal Tract: From Pathophysiology to Clinical Manifestations;Medicina;2023-09-24

3. Comorbidities of COVID-19 Patients;Medicina;2023-07-29

4. Gastrointestinal disorders in post-COVID syndrome. Clinical guidelines;Experimental and Clinical Gastroenterology;2023-05-20

5. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection;Biomedicines;2023-03-27